GMED
Globus Medical, Inc. · Healthcare · Medical - Devices
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +15.1% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 77.22K | $4.52M | n/a | −1 |
| Q2 2026 | 121 | -3 | 71.19M | $5.65B | +7 | −11 |
| Q1 2026 | 128 | +3 | 69.73M | $6.00B | +7 | −5 |
| Q4 2025 | 125 | -2 | 72.17M | $6.30B | +1 | −2 |
| Q3 2025 | 23 | +2 | 41.89M | $2.40B | +2 | −1 |
| Q2 2025 | 19 | -2 | 35.55M | $2.10B | n/a | −2 |
| Q1 2025 | 18 | +2 | 12.57M | $919.97M | +3 | −1 |
| Q4 2024 | 16 | 0 | 17.69M | $1.46B | +1 | −1 |
| Q3 2024 | 15 | 0 | 11.77M | $842.11M | +1 | −1 |
| Q2 2024 | 15 | n/a | 12.93M | $885.43M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 3.59M | n/a | $297.30M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 2.57M | +62.1% | $212.70M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 2.50M | -3.2% | $206.49M | 0.0% | ▼ Trim | 3 | SEC ↗ ×5 |
| 4 | Geode Capital Management ✦ (pasivo) | 1.90M | +0.6% | $156.97M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 1.69M | +161.0% | $140.17M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 6 | Norges Bank ✦ (pasivo) | 1.42M | -22.4% | $117.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 1.14M | +74.9% | $93.98M | 0.1% | ▲ Add | 3 | SEC ↗ ×3 |
| 8 | T. Rowe Price ✦ | 1.12M | -0.9% | $92.89M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 9 | Point72 Asset Management ✦ | 591.75K | +306.5% | $48.94M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Capital World Investors ✦ | 574.50K | 0.0% | $47.52M | 0.0% | Held | 3 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 340.56K | -7.8% | $28.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | GAMCO Investors ✦ | 133.84K | -1.6% | $11.07M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 41.23K | -10.8% | $3.41M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 34.17K | Nuevo | $2.83M | 0.0% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 29.49K | -79.5% | $2.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 15.42K | +3.3% | $1.28M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Gotham Asset Management | $2.83M | 0.0% |
Posición cerrada
| Bridgewater Associates | $2.35M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 598 tenedores, 106.58M acciones, $8.83B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 30.00K acc. · $2.24M
Director · 25.00K acc. · $2.18M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología